Finding New Treatments for Childhood Sarcoma and Rare Cancers

Pediatric Preclinical In Vivo Testing Center for Pediatric Sarcoma and Other Solid Tumors

NIH-funded research Sloan-Kettering Inst Can Research · NIH-11109395

This work aims to discover new drug options for children facing sarcomas and other rare solid tumors.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionSloan-Kettering Inst Can Research NIH-funded
Lab location1 site (New York, United States)
Project IDNIH-11109395 on NIH RePORTER

What this research studies

Our team has developed over 300 models using tumor samples from children with solid tumors, which helps us understand how different cancers behave. We use these models to test many existing and new cancer drugs to see which ones might work best. The goal is to identify promising treatments that can then be further explored in clinical trials for children. This approach helps us quickly find the most effective drugs for specific types of pediatric cancers.

Who could benefit from this research

Good fit: This research is ultimately for children diagnosed with pediatric bone and soft tissue sarcomas, renal tumors, desmoplastic small round cell tumor (DSRCT), and other rare pediatric solid tumors.

Not a fit: Patients not diagnosed with pediatric sarcomas or other rare solid tumors would not directly benefit from this specific preclinical research.

Why it matters

Potential benefit: If successful, this work could lead to new and more effective treatment options for children with difficult-to-treat sarcomas and other rare solid tumors.

How similar studies have performed: This program builds upon an established preclinical testing program that has successfully created a large collection of patient-derived models for pediatric solid tumors.

Where this research is happening

New York, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Anti-Cancer Agents
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.